Acadia Pharmaceuticals (ACAD) PT Raised to $37 at RBC Capital on 'Strong Sales'
Tweet Send to a Friend
(Updated - August 5, 2026 9:16 AM EDT)
RBC Capital analyst Brian Abrahams raised the price target on Acadia ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Brian Abrahams raised the price target on Acadia ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
